Sanofi Dengvaxia Awarded US FDA Priority Review as the World’s First Dengue Vaccine

Sanofi, a French pharmaceutical giant, recently announced that the US Food and Drug Administration (FDA) has accepted the dengue vaccine Dengvaxia’s Biologics License Application (BLA) and granted priority review. The vaccine isRead More…